Please login to the form below
Dinutuximab beta
This page shows the latest Dinutuximab beta news and features for those working in and with pharma, biotech and healthcare.
EUSA receives European green light for kidney cancer treatment Fotivda
field.”. The UK-based group has also recently received another EU approval for the rare cancer drug dinutuximab beta as a treatment for high-risk neuroblastoma patients over the age of
Latest news
-
Keytruda and Opdivo backed for new uses in Europe
CHMP recommendations also include Trumenba, Dinutuximab beta and Refixia. MSD and Bristol-Myers Squibb (BMS) both picked up positive opinions for their PD-1 inhibitors from the EMA's advisory committee ... Apeiron Biologics also got the go-ahead for
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
- Medscape Oncology’s Large Presence at ASH 2023
No results were found
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
